Laser Assisted Hatching for Infertility
(IMPACT Trial)
Trial Summary
What is the purpose of this trial?
This study aims to assess the clinical significance of cleavage stage (Day 3) assisted hatching compared to assisted hatching at the blastocyst stage (Day 5,6,7) of embryo development at the time of trophectoderm (TE) biopsy for patients undergoing in vitro fertilization (IVF) and preimplantation genetic testing for aneuploidy (PGT-A) for treatment of their infertility.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Laser Assisted Hatching for Infertility?
Research suggests that laser-assisted hatching can improve pregnancy and implantation rates, especially in women with a poor prognosis for pregnancy, such as those of advanced age or with previous IVF failures. It is considered one of the best techniques for assisted hatching, potentially leading to better outcomes in assisted reproductive technologies.12345
Is laser-assisted hatching safe for humans?
How does the treatment Laser Assisted Hatching differ from other treatments for infertility?
Laser Assisted Hatching (LAH) is unique because it uses a precise laser to thin or create a small opening in the outer shell of an embryo, which can help improve the chances of implantation and pregnancy, especially in older women or those with a poor prognosis. This method is considered more effective than traditional techniques like using a micropipette, as it can increase pregnancy and implantation rates in assisted reproduction.1291112
Research Team
Jason Fransiak, MD
Principal Investigator
Reproductive Medicine Associates of New Jersey
Eligibility Criteria
This trial is for individuals undergoing IVF with PGT-A due to infertility. It's comparing the timing of a technique called assisted hatching, either on Day 3 at cleavage stage or later on Days 5-7 at blastocyst stage before TE biopsy.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo assisted hatching procedures at either the cleavage stage (Day 3) or blastocyst stage (Day 5, 6, 7) as part of IVF and PGT-A
Follow-up
Participants are monitored for outcomes such as blastulation rate, embryo morphologic grade, and aneuploidy rate
Long-term Follow-up
Participants are monitored for live birth rate, positive pregnancy rate, pregnancy loss rate, and sustained implantation rate
Treatment Details
Interventions
- Laser Assisted Hatching
Find a Clinic Near You
Who Is Running the Clinical Trial?
Reproductive Medicine Associates of New Jersey
Lead Sponsor